- PII
- S0514749225010093-1
- DOI
- 10.31857/S0514749225010093
- Publication type
- Article
- Status
- Published
- Authors
- Volume/ Edition
- Volume 61 / Issue number 1
- Pages
- 109-114
- Abstract
- For the first time, amides of (5Z,9Z)-eicosa-5,9-dienoic acid, which exhibits a high inhibitory activity of topoisomerases I and II, were synthesized using aliphatic and O-containing 1,2-dienes at the key stage of the intermolecular cross-cyclomagnesiation reaction, catalyzed by Cp2TiCl2.
- Keywords
- металлокомплексный катализ реактивы Гриньяра кросс-цикломагнирование 1,2-диены Cp2TiCl2 амиды жирных кислот
- Date of publication
- 16.09.2025
- Year of publication
- 2025
- Number of purchasers
- 0
- Views
- 15
References
- 1. Johanss J.R. Synlett 2019, 30, 213–217. doi 10.1055/s-0037-1611939
- 2. Bezuglov V., Bobrov M., Gretskaya N., Gonchar A., Zinchenko G., Melck D., Bisogno T., Marzo V.Di, Kuklev D., Rossi J.-C., Vidald J.-P., Durand T. Bioorg. Med. Chem. Lett. 2001, 11, 447–449.
- 3. Dionisi M., Alexander S.P.H., Bennett A.J. Lipids Health Disease 2012, 11, 51. doi 10.1186/1476-511X-11-51
- 4. Mueller G.P., Driscoll W.J. Vitamins & Hormones, 2009, 55–78. doi 10.1016/s0083-6729(09)81003-0
- 5. Sancho R. Mol. Pharmacol. 2003, 63 (2), 429–438. doi 10.1124/mol.63.2.429
- 6. Oz M. Curr. Pharm. Des. 2006, 12, 227–239.
- 7. Verme J.L. Molecular Pharmacology 2005, 67 (1), 15–19. doi 10.1124/mol.104.006353
- 8. Petrosino S., Di Marzo V. Brit. J. Pharmacol. 2016, 174 (11), 1349–1365. doi 10.1111/bph.13580
- 9. Takao K., Noguchi K., Hashimoto Y., Shirahat A., Sugita Y. Chem. Pharm. Bull. 2015, 63 (4), 278–285. doi 10.1248/cpb.c14-00881
- 10. Rodriguez de Fonseca F., Navarro M., Gomez R., Escuredo L., Nava F., Fu J., Piomelli D. Nature 2001, 414 (6860), 209–212. doi 10.1038/35102582
- 11. Guzman M., Lo Verme J., Fu J., Oveisi F., Blazquez C., Piomelli D. J. Biol. Chem. 2004, 279 (27), 27849–27854. doi 10.1074/jbc.m404087200
- 12. Petrosino S., Di Marzo V. Handbook Neurochem. Mol. Neurobiol. 2009, 75–98.
- 13. Maione S., Petrocellis L., Novellis V., Moriello A. S., Petrosino S., Palazzo E., Marzo V. Brit. J. Pharmacol. 2007, 150 (6), 766–781. doi 10.1038/sj.bjp.0707145
- 14. Ortar G., Cascio M.G., De Petrocellis L., Morera E., Rossi F., Schiano-Moriello A., Di Marzo V. J. Med. Chem. 2007, 50 (26), 6554–6569. doi 10.1021/jm070678q
- 15. Liu Y., Ji L., Eno M., Kudalkar S., Li A., Schimpgen M., Nikas S. P. J. Med. Chem. 2018, 61, 8639−8657. doi 10.1021/acs.jmedchem.8b00611
- 16. Grabiec U., Dehghani F. Cannabis Cannabinoid Res. 2017, 2 (1), 183–196. doi 10.1089/can.2017.0015
- 17. Burstein S., Salmonsen R. Bioorg. Med. Chem. 2008, 16 (22), 9644–9651. doi 10.1016/j.bmc.2008.10.015
- 18. D’yakonov V.A., Makarov A.A., Dzhemileva L.U., Makarova E.Kh., Khusnutdinova E.K., Dzhemilev U.M. Chem. Commun. 2013, 49, 8401–8403. doi 10.1039/C3CC44926B
- 19. D’yakonov V.A., Dzhemileva L.U., Makarov A.A., Mulyukova A.R., Baev D.S., Khusnutdinova E.K., Tolstikova T.G., Dzhemilev U.M. Bioorg. Med. Chem. Lett., 2015, 25 (11), 2405–2408. doi 10.1016/j.bmcl.2015.04.011
- 20. D’yakonov V.A., Dzhemileva L.U., Makarov A.A., Mulyukova A.R., Baev D.S., Khusnutdinova E.K., Tolstikova T.G., Dzhemilev U.M. Curr. Cancer Drug Targets 2015, 15 (6), 504–510. doi 10.2174/1568009615666150506093155
- 21. D’yakonov V.A., Dzhemileva L.U., Makarov A.A., Mulyukova A.R., Baev D.S., Khusnutdinova E.K., Tolstikova T.G., Dzhemilev U.M. Med. Chem. Res., 2016, 25 (1), 30–39. doi 10.1007/s00044-015-1446-1
- 22. Makarov A.A., Dzhemileva L.U., Salimova A.R., Makarova E.Kh., Ramazanov I.R., D'yakonov V.A., Dzhemilev U.M. Bioorg. Chem., 2020, 104, 104303. doi 10.1016/j.bioorg.2020.104303
- 23. Kojima N., Fushimi T., Tatsukawa T., Yoshimitsu T., Tanaka T., Yamori T., Dan S., Iwasaki H., Yamashita M. Eur. J. Med/ Chem. 2013, 63, 833–839. doi 10.1016/j.ejmech.2013.03.009
- 24. Kuang J., Ma S. J. Org. Chem., 2009, 74, 1763. doi 10.1021/jo802391x
